This study aimed to explore the molecular mechanism of the quinazoline analog kzl052 targeting WRN against prostate cancer and provide a theoretical basis and treatment strategy for targeting WRN helicase in the treatment of prostate cancer. This evidence concerns the gene WRN and prostate cancer.